Cardinal Health vs Henry Schein
Cardinal Health is the larger business, with $254.25bn of revenue in fiscal 2026 against $13.18bn for Henry Schein (19.3 times as much). Cardinal Health grew faster (14.2% against 4.0%). Henry Schein kept more of each dollar of sales as profit: a net margin of 3.0% against 0.7%.
| Latest fiscal year | Cardinal HealthCAH, 2026 | Henry ScheinHSIC, 2025 |
|---|---|---|
| Revenue | $254.25bn | $13.18bn |
| Revenue growth | 14.2% | 4.0% |
| Net income | $1.71bn | $398m |
| Operating margin | 1.0% | 5.0% |
| Net margin | 0.7% | 3.0% |
| Return on equity | — | 12.0% |
| Free cash flow | $4.53bn | $573m |
| Cash | $4.86bn | $156m |
| Total debt | $8.89bn | $3.11bn |
| Debt to equity | — | 95.7% |
| Dividend per share | $2.04 | — |
| Dividend yield | 0.8% | — |
| Share buybacks | $1.36bn | $850m |
| Employees | 63,900 | 25,000 |
| Market value | $60.15bn | $9.21bn |
| Price vs our value range | Within our value range | Within our value range |
| Moat score | 40 (Weak) | 57 (Moderate) |
| Insider trades, 12 months | 0 buys, 35 sales | 1 buys, 10 sales |